Medical Need of OAC Reversal

Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants

NCT02185027 ·Status: COMPLETED

Rivaroxaban Estimation With Warfarin in Atrial Fibrillation Patients With Coronary Stent Implantation Study (REWRAPS)

NCT02024230 ·Status: COMPLETED ·Phase: PHASE4

Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients

NCT02792335 ·Status: COMPLETED

Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists

NCT01722786 ·Status: COMPLETED

Direct Oral Anticoagulants and Venous Thromboembolism

NCT02833987 ·Status: COMPLETED

Reversal of the Antithrombotic Action of New Oral Anticoagulants

NCT01478282 ·Status: UNKNOWN ·Phase: PHASE4

A Phase 2 Study To Evaluate The Safety Of Apixaban In Atrial Fibrillation

NCT00787150 ·Status: COMPLETED ·Phase: PHASE2

Comparative Study of Oral Anticoagulation in Left Ventricular Thrombi

NCT03926780 ·Status: COMPLETED ·Phase: PHASE3

Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over

NCT02286414 ·Status: COMPLETED

Anticoagulant Versus Dual Antiplatelet Therapy for Preventing Leaflet Thrombosis and Cerebral Embolization After Transcatheter Aortic Valve Replacement

NCT03284827 ·Status: COMPLETED ·Phase: PHASE4

Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation

NCT02666157 ·Status: UNKNOWN ·Phase: PHASE4

The DARE Warfarin CER Study

NCT03271450 ·Status: UNKNOWN

Study to Gather Information About the Safety of Oral Anticoagulation Drugs and How Well These Drugs Work in Real World for Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem)

NCT04249401 ·Status: COMPLETED

Non-interventional, Retrospective Cohort Study to Explore OAC Treatment in Korea

NCT03572972 ·Status: COMPLETED

Reversal of Dabigatran Anticoagulant Effect With Idarucizumab

NCT02104947 ·Status: COMPLETED ·Phase: PHASE3

A Study to Learn About Venous Thromboembolism (VTE) Treatment With Rivaroxaban in Japanese Patients Using a Claims Database

NCT04923139 ·Status: COMPLETED

Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients

NCT06947707 ·Status: RECRUITING

Evaluating Medication Adherence to Novel Oral Anticoagulants With Anticoagulant Activity Monitoring in Patients With Atrial Fibrillation

NCT03666962 ·Status: UNKNOWN

Rivaroxaban for Patients With Antiphospholipid Syndrome

NCT02926170 ·Status: COMPLETED ·Phase: PHASE3

Venous Thromboembolism (VTE) Treatment Study in Japanese Pulmonary Embolism (PE) Patients

NCT01516814 ·Status: COMPLETED ·Phase: PHASE3

An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation

NCT00403767 ·Status: COMPLETED ·Phase: PHASE3

Anticoagulant Utilization Pattern

NCT01847560 ·Status: COMPLETED

Replication Of An Early Evaluation Of 30-Day Readmissions Among Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran, Rivaroxaban, Apixaban, or Warfarin In The U.S

NCT02769078 ·Status: COMPLETED

Evaluation of the Interference of Antithrombotic Agents With Laboratory Monitoring of Heparin Therapy

NCT02839434 ·Status: TERMINATED

Edoxaban and Frailty in Senior Individuals

NCT03524924 ·Status: COMPLETED